Group One Trading, L.P. Atai Life Sciences N.V. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Group One Trading, L.P. holds 37,753 shares of ATAI stock, worth $210,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,753
Previous 57,796
34.68%
Holding current value
$210,661
Previous $78,000
5.13%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATAI
# of Institutions
111Shares Held
31.3MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$43 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$30.3 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$19.5 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$14.7 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$7.29 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $926M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...